Lila PrescottOct 17, 2026 5 min read

Trump Administration Moves to Expand Access to Peptides Favored by RFK Jr.

WASHINGTON, DC - OCTOBER 05: U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. speaks during an event at the U.S. Department of Health and Human Services (HHS) building on October 05, 2026 in Washington, DC. HHS, Labor and Treasury officials gathered to discuss transparency in healthcare pricing. (Photo by Finn Gomez/Getty Images)
U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. speaks during an event at the U.S. Department of Health and Human Services (HHS) building. | Getty Images

The Trump administration is moving forward with a plan that could make it easier for Americans to get peptides, the trendy wellness injections championed by Health Secretary Robert F. Kennedy Jr.

The Department of Health and Human Services has sent a peptides "interim access policy" to the White House for review, according to a government website posting Thursday. The plan went to the Office of Management and Budget, which reviews federal rules that could have a significant economic impact, The Associated Press reported.

What the Plan Would Do

The White House filing did not include details, and HHS did not respond to requests for comment. But two people familiar with the plan told the AP it would let compounding pharmacies temporarily make some popular peptides, including BPC-157, which is promoted for building muscle and healing injuries.

WASHINGTON, DC - MAY 18: U.S. President Donald Trump, with U.S. Health and Human Services Secretary Robert F. Kennedy Jr. (L) looking on, speaks in the Eisenhower Executive Office Building on May 18, 2026 in Washington, DC. President Trump spoke on the TrumpRX site, prescription drugs, and health care affordability during the event.  (Photo by Chip Somodevilla/Getty Images)
U.S. President Donald Trump, with U.S. Health and Human Services Secretary Robert F. Kennedy Jr. | Getty Images

The approach relies on what is known as enforcement discretion. That means the Food and Drug Administration would simply choose not to go after pharmacies producing certain peptides.

RFK Jr. during a Department of Homeland Security tour of the National Biodefense Analysis and Countermeasures Center in 2025. | Wikimedia Commons / DHSgov / Public Domain
RFK Jr. during a Department of Homeland Security tour of the National Biodefense Analysis and Countermeasures Center in 2025. | Wikimedia Commons / DHSgov / Public Domain

Formally adding peptides to the FDA's list of substances considered safe for compounding would require a federal rulemaking process. That could take years and involve multiple rounds of public comment. It is unclear whether the administration plans to take that route.

What Are Peptides?

Peptides are short chains of amino acids, the building blocks of proteins. In the body, they trigger hormones involved in growth, metabolism and healing.

SALT LAKE CITY, UT - OCTOBER 14: Peptide's are frozen with liquid nitrogen to store them until they are used to see if they are a potential new drug candidates for testing against a part of Ebola that is vulnerable to drugs, at the University of Utah on October 14, 2014 in Salt Lake City, Utah.  Dr. Michael Kay says this breakthrough if proven to be effective, won't help the current outbreak of Ebola but he hopes it will be able to prevent the next one in the coming years on all the strains of Ebola not just one. (Photo by George Frey/Getty Images)
Peptide's are frozen with liquid nitrogen to store them. | Getty Images

Some peptide drugs, including GLP-1 medications for diabetes and weight loss, have been thoroughly tested and approved. The peptides at the center of this plan have not gone through that review. People seek them out to bulk up, look younger and boost energy, but those uses are not FDA-approved, and most of the available data comes from animal studies.

Medical Drug Production Plant. Insulin Injection Pens on Conveyor Line during Production Process at Modern Pharmaceutical Factory. Weight Loss Medication Manufacturing.
Adobe Stock

Many users inject peptides under the skin, sometimes combining several at once, NPR reported. For anyone curious about trying them, experts suggest mastering a few healthy habits first.

Safety Concerns Remain

The FDA had placed BPC-157 and more than a dozen other injectable peptides on its list of substances too risky to compound. The agency has cited potential risks including contamination, allergic reactions and tumor growth.

SALT LAKE CITY, UT - OCTOBER 14:  Bottles that contains a peptide's, are put in trays before Mark Petersen test them in a mass spectrometer to see if they are pure enough to be potential new drug candidates for testing against a part of Ebola that is vulnerable to drugs, at the University of Utah, works in his office on a structural modeling of part of the Ebola virus he discovered that is vulnerable to drug and thus treatment on October 14, 2014 in Salt Lake City, Utah.  Dr. Kay says this breakthrough if proven to be effective, won't help the current outbreak of Ebola but he hopes it will be able to prevent the next one in the coming years on all the strains of Ebola not just one. (Photo by George Frey/Getty Images)
Getty Images

Earlier this year, Kennedy directed the FDA to reconsider a short list of these substances. In July, an outside FDA advisory panel selected by HHS recommended dropping restrictions on six of the seven peptides it reviewed. The panel included doctors, pharmacists and consultants who work in the peptide field.

FDA staff scientists disagreed. They said none of the peptides had been studied enough to show they are safe and effective.

WASHINGTON, DC - JANUARY 16: U.S. President Donald Trump speaks as (L-R) U.S. Secretary of Agriculture Brooke Rollins, U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. and Administrator for the Centers for Medicare & Medicaid Services Mehmet Oz look on during a "Great, Historic Investment in Rural Health Roundtable" in the East Room of the White House on January 16, 2026 in Washington, DC. Trump promoted a 50-state, $50 billion rural health program that aims to help communities where hospitals are struggling and residents have a hard time finding care, made worse by Republican-led Medicaid cuts that were part of 2025's One Big Beautiful Bill. (Photo by Chip Somodevilla/Getty Images)
Getty Images

Chemical biologist Eileen Kennedy has warned of possible harm to the liver and kidneys, or a dangerous immune reaction. "They're injecting themselves with things that are potentially dangerous," integrative medicine specialist Dr. Myles Spar told NPR, referring to people who buy peptides from unregulated sources.

Kennedy's Push to End the "War" on Peptides

Before joining the administration, Kennedy declared that the "FDA's war" on peptides and other wellness products would soon end. As health secretary, he has argued that U.S. compounding pharmacies should be allowed to sell peptides because Americans are already turning to "gray market" products made in China and elsewhere. Those products remain widely available online, including on TikTok.

BENSENVILLE, ILLINOIS - SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images)
Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press. | Getty Images

Some supporters of the change see it as a way to bring those products under oversight. FDA law expert Robin Feldman told NPR that doing so is "probably a good move," but said the agency would need to follow up to prevent misleading marketing and new black-market sellers.

A Booming Business

Wall Street analysts estimate the peptide market could be worth $2 billion to $3 billion. Telehealth companies Hims & Hers and Noom have both announced plans to offer peptides if federal access is eased, and some of the biggest names in the "Make America Healthy Again" movement sell peptide injections and supplements.

WASHINGTON, DC - NOVEMBER 12: U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. (L) welcomes Vice President JD Vance (R) for a discussion during The Official MAHA Summit at Waldorf Astoria Hotel on November 12, 2025 in Washington, DC. Top Trump administration officials, executives and influencers gathered to discuss the “Make America Healthy Again” agenda at the summit. (Photo by Alex Wong/Getty Images)
U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. (L) welcomes Vice President JD Vance (R) for a discussion during The Official MAHA Summit. | Getty Images

Brigham Buhler, a wellness clinic operator who sells peptides online, praised the proposal on X, calling it "huge."


Curious for more stories that keep you informed and entertained? From the latest headlines to everyday insights, YourLifeBuzz has more to explore. Dive into what’s next.

Explore by Topic